Adverse Events Module

Adverse Events Module

For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.

Adverse Events Module path is as follows:

Study -> Results Section -> Adverse Events Module -> Event Groups

Study -> Results Section -> Adverse Events Module -> Serious Events

Study -> Results Section -> Adverse Events Module -> Other Events

Adverse Events Module


Ignite Creation Date: 2025-12-26 @ 11:00 AM
Ignite Modification Date: 2025-12-26 @ 11:00 AM
NCT ID: NCT05216406
Description: Self-report at the end of the trial.
Frequency Threshold: 1
Time Frame: 1 day
Study: NCT05216406
Study Brief: Effects of Daily Supplementation of 5-HTP on Body Composition
Event Groups(If Any):

Event Groups

Title Description Deaths # Affected Deaths # At Risk Serious # Affected Serious # At Risk Other # Affected Other # At Risk View
5-HTP The dietary supplement (100 mg of 5-hydroxytryptophan; CLEANMOOD™) was provided by NURA™ (Irvine, California USA). Subjects were instructed to consume one capsule daily at their convenience for 8 weeks. 5-HTP: CLEANMOOD is an organic 5-Hydroxytryptophan (5-HTP) ingredient. 0 None 0 31 3 31 View
Control The placebo consisted of maltodextrin. Subjects were instructed to consume one capsule daily at their convenience for 8 weeks. Placebo: Maltodextrin capsule 0 None 0 17 2 17 View
Serious Events(If Any):
Other Events(If Any):

Other Events

Term Type Organ System Vocab View
Upset Stomach NON_SYSTEMATIC_ASSESSMENT Gastrointestinal disorders None View